-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Events
Latest From Events
Discover Trends and Investment Opportunities at the BIO Investor Forum
The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences. The Forum will include candid fireside chats between biopharma CEOs, analysts, and other industry experts. Come hear about recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2016. Read More >
Share your Cutting Edge Ideas at the 2016 BIO International Convention
After a record-breaking event this year in Philadelphia, the BIO International Convention will return to San Francisco, California in 2016 with its sights set on creating another historic industry event. BIO is seeking cutting edge, engaging, and thought-provoking session ideas and prospective speakers for BIO 2016, which will be held June 6-9, 2016 in San Francisco. “We are planning to make this year’s event our best Convention ever by providing attendees with the education and Read More >
The Investment Landscape in Brazil
Brazil has been at the forefront of biotech news recently, with China announcing plans to invest $250B and the recently signed Joint Communique with the U.S. government reaffirming their commitment to strengthening traditional ties, expand trade, and investment cooperation. Brazil is now one of the most attractive and promising biotech markets in the world—human health, agribusiness, raw materials and environmental—and investing in Brazil has become a new priority. Rather than leave innovation financing solely to Read More >
Congratulations to the 2015 Buzz of BIO at the BIO Investor Forum Winners!
BIO is pleased to announce the winners of the 2015 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. Taking place October 20-21, 2015 at the Parc 55 Hotel in San Francisco, California, the 14th Annual BIO Investor Forum will focus on investment opportunities for early stage and established private companies as well as emerging public companies. “This year’s Buzz of BIO winners exemplify the diversity of companies and Read More >
Opportunities for VC Funding Abound in San Francisco
If you’re an emerging biotech company looking for your first round of funding, the BIO Investor Forum in San Francisco may be your best bet to connect with the right investors. Small biotech startups are finding massive success in the Bay Area as venture capitalists turn their gaze from social networking and tech companies towards the biotechnology industry. Investors are realizing that the rewards for supporting early stage biotechs are potentially greater than for supporting Read More >
